ASPIRIANT, LLC: GSK position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ASPIRIANT, LLC on GSK, newest first. How the timeline and the estimate are built.
ASPIRIANT, LLC held 10,267 GSK shares at 2026-06-30 per its 13F-HR filed 2026-07-20.
the latest 13F is the newest step
- period ended2026-06-3013F 10,267 sharesChange vs previous 13F +1,773 shares
0.01% of the 13F portfolio, value $538,196.
13F-HR 0001172661-26-002689 filed by ASPIRIANT, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 8,494 sharesChange vs previous 13F +309 shares
0.01% of the 13F portfolio, value $468,784.
13F-HR 0001172661-26-001732 filed by ASPIRIANT, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 8,185 sharesChange vs previous 13F +185 shares
0.01% of the 13F portfolio, value $401,392.
13F-HR 0001172661-26-000216 filed by ASPIRIANT, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 8,000 sharesChange vs previous 13F -119 shares
0.01% of the 13F portfolio, value $345,280.
13F-HR 0001172661-25-004424 filed by ASPIRIANT, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 8,119 sharesChange vs previous 13F -122 shares
0.01% of the 13F portfolio, value $311,770.
13F-HR 0001172661-25-002762 filed by ASPIRIANT, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 8,241 sharesChange vs previous 13F not available
0.01% of the 13F portfolio, value $319,256.
13F-HR 0001172661-25-001518 filed by ASPIRIANT, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).